Glucose-Lösung Deltamedica (Glucose, Anhydrous)

Glucose-Lösung Deltamedica is employed in clinical settings where rapid carbohydrate delivery is required. It supports several therapeutic objectives:

• Treatment of hypoglycemia by raising blood glucose levels.
• Provision of an energy substrate during parenteral nutrition.
• Fluid and electrolyte replacement in patients unable to take oral intake.
• Support during perioperative care to maintain glucose homeostasis.
• Adjunctive therapy in critical care for metabolic support.

Glucose-Lösung Deltamedica may be associated with a range of adverse reactions, most of which are related to its intravenous administration.

Common

• Local irritation at the infusion site.
• Mild hyperglycemia.
• Nausea or vomiting.
• Transient electrolyte imbalance.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic or anaphylactic reaction.
• Phlebitis or thrombophlebitis.
• Fluid overload, especially in patients with cardiac or renal impairment.

When using Glucose-Lösung Deltamedica, clinicians should consider several safety measures to minimize risk:

• Assess blood glucose levels before and during infusion.
• Adjust infusion rate in patients with diabetes or impaired glucose tolerance.
• Monitor fluid balance to avoid overload in heart failure or renal disease.
• Use aseptic technique to prevent contamination and infection.
• Evaluate electrolyte status, particularly sodium and potassium, during therapy.
• Document any signs of hypersensitivity promptly.

Glucose-Lösung Deltamedica can interact with other medications or clinical conditions, requiring careful management.

Avoid

• Concurrent administration of high‑dose insulin without appropriate glucose monitoring.
• Co‑infusion with solutions containing incompatible electrolytes (e.g., calcium chloride).

Use with caution

• Beta‑blockers, which may mask hypoglycemia symptoms.
• Corticosteroids, which can increase blood glucose levels.
• Diuretics that may alter fluid and electrolyte balance.
• Medications that affect renal function, such as ACE inhibitors.